Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis

被引:0
|
作者
Manuel A Friese
Karen B Jakobsen
Lone Friis
Ruth Etzensperger
Matthew J Craner
Róisín M McMahon
Lise T Jensen
Véronique Huygelen
E Yvonne Jones
John I Bell
Lars Fugger
机构
[1] Medical Research Council Human Immunology Unit,Department of Clinical Neurology
[2] Weatherall Institute of Molecular Medicine,Division of Structural Biology
[3] John Radcliffe Hospital,undefined
[4] University of Oxford,undefined
[5] Weatherall Institute of Molecular Medicine,undefined
[6] John Radcliffe Hospital,undefined
[7] University of Oxford,undefined
[8] Institut für Neuroimmunologie und Klinische MS-Forschung,undefined
[9] Zentrum für Molekulare Neurobiologie,undefined
[10] Universitätsklinikum Hamburg-Eppendorf,undefined
[11] The Henry Wellcome Building for Genomic Medicine,undefined
[12] University of Oxford,undefined
[13] Clinical Institute,undefined
[14] Aarhus University Hospital,undefined
[15] Skejby Sygehus,undefined
[16] Office of the Regius Professor of Medicine,undefined
[17] The Richard Doll Building,undefined
[18] Roosevelt Drive,undefined
[19] University of Oxford,undefined
来源
Nature Medicine | 2008年 / 14卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Although major histocompatibility complex (MHC) class II alleles and CD4+ T cells have been implicated in multiple sclerosis, Friese et al. provide here the first direct evidence incriminating MHC class I genes and CD8+ T cells in the pathogenesis of this autoimmune disorder (pages 1150–1151).
引用
收藏
页码:1227 / 1235
页数:8
相关论文
共 50 条
  • [1] Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis
    Friese, Manuel A.
    Jakobsen, Karen B.
    Friis, Lone
    Etzensperger, Ruth
    Craner, Matthew J.
    McMahon, Roisin M.
    Jensen, Lise T.
    Huygelen, Veronique
    Jones, E. Yvonne
    Bell, John I.
    Fugger, Lars
    NATURE MEDICINE, 2008, 14 (11) : 1227 - 1235
  • [2] Autoreactive Regulatory CD8+ T Cells in Multiple Sclerosis
    Baughman, Ethan
    Mendoza, Jason
    Frohman, Elliot
    Karandikar, Nitin
    CLINICAL IMMUNOLOGY, 2010, 135 : S44 - S45
  • [3] HLA class I antigens modulate activity of CD8+ T cells in multiple sclerosis
    Nature Clinical Practice Neurology, 2009, 5 (2): : 64 - 65
  • [4] Autoreactive CD8+ T cells in multiple sclerosis:: a new target for therapy?
    Friese, MA
    Fugger, L
    BRAIN, 2005, 128 : 1747 - 1763
  • [5] CD8+ T cells in multiple sclerosis
    Denic, Aleksandar
    Wootla, Bharath
    Rodriguez, Moses
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (09) : 1053 - 1066
  • [6] Involvement of CD8+ T Cells in Multiple Sclerosis
    Salou, Marion
    Nicol, Bryan
    Garcia, Alexandra
    Laplaud, David-Axel
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [7] Pathogenic CD8+ T Cells in Multiple Sclerosis
    Friese, Manuel A.
    Fugger, Lars
    ANNALS OF NEUROLOGY, 2009, 66 (02) : 132 - 141
  • [8] Oligoclonality of CD8+ T cells in multiple sclerosis
    Monteiro, J
    Hingorani, R
    Peroglizzi, R
    Apatoff, B
    Gregersen, PK
    AUTOIMMUNITY, 1996, 23 (02) : 127 - 138
  • [9] Are HLA-E Restricted CD8+ T Cells Functionally Altered in Multiple Sclerosis?
    Pannemans, Kim
    Goris, An
    Dobosi, Rita
    Dubois, Benedicte
    van Wijmeersch, Bart
    Stinissen, P.
    Hellings, Niels
    CLINICAL IMMUNOLOGY, 2009, 131 : S125 - S125
  • [10] Immune regulation of multiple sclerosis by CD8+ T cells
    Sushmita Sinha
    Farah R. Itani
    Nitin J. Karandikar
    Immunologic Research, 2014, 59 : 254 - 265